Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

OBJECTIVES: This is the first clinical trial of this type in Japan, designed to analyze two important aspects of Alzheimer’s disease (AD) management using medium-chain triglycerides. Axona was administered for 3 months (40 g of powder containing 20 g of caprylic triglycerides). We used an indurating...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnuma, Tohru, Toda, Aiko, Kimoto, Ayako, Takebayashi, Yuto, Higashiyama, Ryoko, Tagata, Yuko, Ito, Masanobu, Ota, Tsuneyoshi, Shibata, Nobuto, Arai, Heii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712972/
https://www.ncbi.nlm.nih.gov/pubmed/26811674
http://dx.doi.org/10.2147/CIA.S95362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712972/
https://www.ncbi.nlm.nih.gov/pubmed/26811674
http://dx.doi.org/10.2147/CIA.S95362

Ejemplares similares